Clinical trial
Levitra (Vardenafil, BAY38-9456) Partner Satisfaction Study II
NCT00377793 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00377793 |
|---|---|
| Title | Levitra (Vardenafil, BAY38-9456) Partner Satisfaction Study II |
| Official title | A Randomized, Double Blind, Parallel Group Study of Vardenafil Flexible Dose Versus Placebo in Males With Erectile Dysfunction and Their Female Partners Sexual Quality of Life. PARTNER II |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Sexual Dysfunction, Male Erectile Dysfunction |
| Intervention type | Drug |
| Interventions | Levitra (Vardenafil, BAY38-9456), Placebo |
| Enrollment | 352 |
| Start date | Jul 1, 2006 |
| Completion | Aug 1, 2007 |
| First posted | Sep 18, 2006 |
| Last update posted | Dec 24, 2014 |
| Countries | Belgium, France, Germany, Italy, Netherlands, South Africa, Spain |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: